dPCR（デジタルPCR）及びqPCR（定量PCR）の世界市場：PCR装置、PCR用試薬・消耗品、PCRソフトウェア、PCRサービス...市場調査レポートについてご紹介

Table Of Contents

1 Introduction (Page No. – 20)
1.1 Study Objectives
1.2 Digital PCR and qPCR Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered For The Study
1.4 Currency And Pricing
1.5 Package Size
1.6 Limitations
1.7 Digital PCR and qPCR Market Stakeholders

2 Research Methodology (Page No. – 25)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown Of Primaries
2.2 Factor Analysis
2.2.1 Introduction
2.2.2 Demand-Side Analysis
2.2.2.1 Healthcare Expenditure Patterns
2.2.2.2 Rapid Growth Of Aging Population
2.2.2.3 Incidence And Prevalence Of Cancer
2.2.2.4 Birth Rate /Pregnancies
2.2.2.5 Burden Of Infectious Diseases
2.2.2.6 Number Of Clinical, Forensic, And Research Laboratories
2.2.3 Supply-Side Analysis
2.2.3.1 Number Of New Product Launches: qPCR And dPCR Vs. Competitive Technologies
2.2.3.2 Parent Market Analysis: Polymerase Chain Reaction (PCR) Market
2.3 Digital PCR and qPCR Market Size Estimation
2.3.1 Top-Down Approach
2.3.2 Bottom-Up Approach
2.4 qPCR And Digital PCR Market Breakdown And Data Triangulation
2.5 Research Assumptions And Limitations
2.5.1 Assumptions
2.5.2 Limitations

3 Executive Summary (Page No. – 48)
3.1 Introduction
3.2 History, Evolution, And Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 54)
4.1 Attractive Market Opportunities In The qPCR And Digital PCR Market
4.2 Global qPCR And dPCR Technology Market, By Region (2014–2019)
4.3 Top 3 qPCR/dPCR Application Markets, By Region (2014)
4.4 Global qPCR And Digital PCR Market, By Product (2014–2019)
4.5 Global qPCR And Digital PCR Market, By End User (2014–2019)

5 Market Overview (Page No. – 59)
5.1 Introduction
5.2 Digital PCR and qPCR Market Segmentation
5.2.1 qPCR And Digital PCR Market, By Technology
5.2.2 qPCR And Digital PCR Market, By Product
5.2.3 qPCR And Digital PCR Market, By End User
5.2.4 qPCR And Digital PCR Market, By Application
5.3 Evolution
5.4 Digital PCR and qPCR Market Dynamics
5.4.1 Drivers
5.4.1.1 Growing Geriatric Population
5.4.1.2 Technological Advancements
5.4.1.3 Rising Incidence Of Infectious Diseases And Genetic Disorders
5.4.1.4 Increasing Public-Private Investments, Funds, And Grants
5.4.2 Restraints
5.4.2.1 High Cost Of dPCR Instruments
5.4.2.2 Limitations Of qPCR And dPCR Techniques
5.4.3 Opportunities
5.4.3.1 Successful Completion Of Human Genome Project
5.4.3.2 Growing Market Penetration In Emerging Countries
5.4.3.3 Shift From Plant-Derived To Genome-Based Drug Discovery
5.4.4 Challenges
5.4.4.1 Adoption, Implementation Miqe Guidelines For Publishing qPCR And dPCR-Based Research

6 Industry Trends (Page No. – 73)
6.1 Introduction
6.2 Value Chain Analysis
6.3 Industry Trends
6.3.1 Technology Integration To Accelerate DNA Analysis Process
6.3.2 Development Of Lab-On-Chip PCR Devices
6.3.3 Advancements In Probe Technology To Enhance qPCR Sensitivity
6.4 Porter’s Five Forces Analysis
6.4.1 Threat From New Entrants
6.4.2 Threat From Substitutes
6.4.3 Bargaining Power Of Suppliers
6.4.4 Bargaining Power Of Buyers
6.4.5 Intensity Of Competitive Rivalry

7 Global qPCR And dPCR Market, By Technology (Page No. – 82)
7.1 Introduction
7.2 Quantitative PCR ( qPCR)
7.3 Digital PCR (dPCR)

8 Global qPCR And dPCR Market, By Product And Services (Page No. – 88)
8.1 Introduction
8.2 qPCR Products Market
8.2.1 qPCR Instruments Market
8.2.2 qPCR Reagents And Consumables Market
8.2.3 qPCR Software And Services Market
8.3 dPCR Products Market
8.3.1 dPCR Instruments Market
8.3.2 dPCR Reagents And Consumables Market
8.3.3 dPCR Software And Services Market

9 PCR And dPCR Market, By Application (Page No. – 101)
9.1 Introduction
9.2 Quantitative PCR ( qPCR)
9.2.1 Clinical Applications
9.2.2 Research Applications
9.2.3 Forensic Applications
9.3 Digital PCR (dPCR)
9.3.1 Clinical Applications
9.3.2 Research Applications
9.3.3 Forensic Applications

10 qPCR And dPCR Market, By End User (Page No. – 113)
10.1 Introduction
10.1.1 Research Laboratories And Academic Institutes
10.1.2 Pharmaceutical And Biotechnology Companies
10.1.3 Hospitals And Diagnostic Centers
10.1.4 Clinical Research Organizations
10.1.5 Forensic Laboratories

11 qPCR And dPCR Market, By Region (Page No. – 127)
11.1 Introduction
11.2 North America
11.3 Europe
11.4 Asia-Pacific
11.5 Rest Of The World (ROW)

12 Competitive Landscape (Page No. – 146)
12.1 Overview
12.2 Digital PCR and qPCR Market Share Analysis, By Key Player, 2013
12.3 Competitive Scenario
12.4 Recent Developments
12.4.1 New Product Launches And Product Enhancements
12.4.2 Agreements, Partnerships, And Collaborations
12.4.3 Geographical Expansions
12.4.4 Mergers And Acquisitions
12.4.5 Other Developments

13 Company Profiles (Page No. – 157)
13.1 Introduction
13.1.1 Geographic Revenue Mix
13.1.2 Strategic Benchmarking
13.1.2.1 Technological Advancements And Product Enhancements
13.1.2.2 Entry Into Asia-Pacific Market
13.2 Agilent Technologies, Inc.
13.2.1 Business Overview
13.2.2 Products & Services
13.2.3 Key Strategies
13.2.4 Recent Developments
13.2.5 SWOT Analysis
13.3 Biomérieux Sa
13.3.1 Business Overview
13.3.2 Products & Services
13.3.3 Key Strategies
13.3.4 Recent Developments
13.4 Bio-Rad Laboratories, Inc.
13.4.1 Business Overview
13.4.2 Products & Services
13.4.3 Key Strategies
13.4.4 Recent Developments
13.4.5 SWOT Analysis
13.5 Biosistemika, Research And Development Llc
13.5.1 Business Overview
13.5.2 Product Portfolio
13.6 Eppendorf Ag
13.6.1 Business Overview
13.6.2 Product Portfolio
13.6.3 Key Strategies
13.6.4 Recent Developments
13.7 F. Hoffman-La Roche Ltd. (Switzerland)
13.7.1 Business Overview
13.7.2 Products & Services
13.7.3 Key Strategies
13.7.4 Recent Developments
13.7.5 SWOT Analysis
13.8 Fluidigm Corporation (U.S.)
13.8.1 Business Overview
13.8.2 Product Portfolio
13.8.3 Key Strategies
13.8.4 Recent Developments
13.9 Qiagen N.V.
13.9.1 Business Overview
13.9.2 Product Portfolio
13.9.3 Key Strategies
13.9.4 Recent Developments
13.9.5 SWOT Analysis
13.1 Raindance Technologies, Inc.
13.10.1 Business Overview
13.10.2 Product Portfolio
13.10.3 Key Strategies
13.10.4 Recent Developments
13.11 Takara Bio, Inc.
13.11.1 Business Overview
13.11.2 Product Portfolio
13.11.3 Key Strategies
13.11.4 Recent Developments
13.12 Thermo Fisher Scientific, Inc.
13.12.1 Business Overview
13.12.2 Products & Services
13.12.3 Key Strategies
13.12.4 Recent Developments
13.12.5 SWOT Analysis

14 Appendix (Page No. – 200)
14.1 Insights Of Industry Experts
14.2 Discussion Guide
14.3 Company Developments
14.3.1 Bio-Rad Laboratories, Inc. (U.S.)
14.3.2 F. Hoffmann-La Roche Ltd. (Switzerland)
14.3.3 Qiagen N.V. (Netherlands)
14.3.4 Raindance Technologies, Inc. (U.S.)
14.3.5 Thermo Fisher Scientific, Inc. (U.S.)
14.4 Introducing Rt: Real Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports